SEOUL: South Korea and COVID-19 vaccine maker Moderna Inc are in discussions over a $200 million investment by the U.S. drugmaker to build a vaccine manufacturing factory in the country, a former government minister who was involved in the talks said.
Park Young-sun, who stepped down last month as minister for SMEs and Startups to run for Seoul mayor, made the comments in an interview with the Asia Business Daily. She also said Moderna was highly interested in the Asian market, according to the report.
Her campaign official confirmed the report to Reuters. Moderna did not immediately respond to a request for comment.
“Moderna has expressed its interest to invest $200 million … and I’ll continue to participate in the discussion for a while, as I had held talks with them as a minister,” Park, was quoted as saying.
The campaign official also told Reuters the factory will likely be built in the capital Seoul.
It has yet to be decided when and by how much the plant will be able…
